Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Eton Pharmaceuticals, Inc. (ETON)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/23/2022 |
4
| BRYNJELSEN SEAN (CEO) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $2.1042, valued at
$21k
|
|
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Adams Jennifer McKie (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.78, valued at
$189k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Troutman William Wilson (CFO and Secretary) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.78, valued at
$56.7k
|
|
| 02/28/2022 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.78, valued at
$189k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 25,000 shares
@ $4.6685, valued at
$116.7k
|
|
| 11/17/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 2,500 shares
@ $4.8016, valued at
$12k
Sold 500 shares
@ $4.8016, valued at
$2.4k
Sold 11,500 shares
@ $4.8619, valued at
$55.9k
Sold 938 shares
@ $4.8619, valued at
$4.6k
|
|
| 11/09/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 159,300 shares
@ $6.3011, valued at
$1M
Sold 8,401 shares
@ $6.3011, valued at
$52.9k
Sold 50,000 shares
@ $6.101, valued at
$305.1k
Sold 2,661 shares
@ $6.101, valued at
$16.2k
|
|
| 11/05/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 110,000 shares
@ $6.5309, valued at
$718.4k
Sold 6,500 shares
@ $6.5309, valued at
$42.5k
Sold 81,700 shares
@ $6.437, valued at
$525.9k
Sold 4,000 shares
@ $6.437, valued at
$25.7k
|
|
| 10/13/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 41,000 shares
@ $5.0002, valued at
$205k
Sold 2,692 shares
@ $5.0002, valued at
$13.5k
Sold 32,500 shares
@ $5.0062, valued at
$162.7k
Sold 1,601 shares
@ $5.0062, valued at
$8k
Sold 82,500 shares
@ $5.0567, valued at
$417.2k
Sold 4,807 shares
@ $5.0567, valued at
$24.3k
|
|
| 08/20/2021 |
4
| Troutman William Wilson (CFO, Treasurer & Secretary) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $4.43, valued at
$22.2k
|
|
| 08/20/2021 |
4
| BRYNJELSEN SEAN (President & CEO) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $4.32, valued at
$43.2k
|
|
| 08/06/2021 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Sold 100,000 shares
@ $5.7514, valued at
$575.1k
Sold 4,000 shares
@ $5.7514, valued at
$23k
Sold 150,000 shares
@ $5.8532, valued at
$878k
Sold 5,500 shares
@ $5.8532, valued at
$32.2k
Sold 330,000 shares
@ $5.8402, valued at
$1.9M
Sold 15,000 shares
@ $5.8402, valued at
$87.6k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Troutman William Wilson (CFO and Secretary) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $8.61, valued at
$1.1M
|
|
| 05/05/2021 |
4
| Adams Jennifer McKie (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 28,133 options to buy
@ $8.61, valued at
$242.2k
|
|
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| BAUM MARK L (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 27,400 options to buy
@ $3.58, valued at
$98.1k
|
|
| 03/16/2020 |
4
| Troutman William Wilson (CFO, Treasurer & Secretary) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 186,200 options to buy
@ $3.58, valued at
$666.6k
|
|
| 03/16/2020 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 27,400 options to buy
@ $3.58, valued at
$98.1k
|
|
| 03/16/2020 |
4
| MAIER PAUL V (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 27,400 options to buy
@ $3.58, valued at
$98.1k
|
|
| 03/16/2020 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 27,400 options to buy
@ $3.58, valued at
$98.1k
|
|
| 03/16/2020 |
4
| BRYNJELSEN SEAN (President & CEO) has filed a Form 4 on Eton Pharmaceuticals, Inc.|
Txns:
| Granted 490,000 options to buy
@ $3.58, valued at
$1.8M
|
|
|
|
|